Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT03482440 Recruiting - Preeclampsia Clinical Trials

Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

Start date: August 26, 2018
Phase: Early Phase 1
Study type: Interventional

Women who develop preeclampsia during pregnancy are more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to blood vessel damage and increased inflammation that occurs during the preeclamptic pregnancy and persists postpartum. The purpose of this investigation is to 1) determine the mechanisms contributing to this lasting blood vessel damage and chronic inflammation, and to 2) identify factors (both physiological and pharmacological) that mitigate these negative effects in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.

NCT ID: NCT03478280 Recruiting - Psoriasis Clinical Trials

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Start date: September 15, 2018
Phase: Phase 4
Study type: Interventional

A randomised, double-blind, placebo-controlled, trial to evaluate the efficacy of brodalumab monotherapy on vascular and systemic inflammation by 18F-FDG-PET/CT in subjects with moderate-to-severe plaque-type psoriasis who are candidates for systemic therapy

NCT ID: NCT03472781 Completed - Clinical trials for Intraocular Inflammation in Children

Demographics and Clinical Characteristics of Paediatric Intraocular Inflammation in Singapore

Start date: January 1, 2017
Phase:
Study type: Observational

Data on demographics, etiology, clinical features, diagnosis, secondary complications, treatment and outcomes of intraocular inflammation in children aged 16 years and below that presented to uveitis clinic in Singapore National Eye Centre (SNEC) from January 1989 to January 2017, will be retrieved and analyzed from the uveitis database retrospectively. The results will be compared with other published studies on different study populations.

NCT ID: NCT03472456 Completed - Clinical trials for Endodontic Inflammation

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

Start date: March 22, 2018
Phase:
Study type: Observational

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

NCT ID: NCT03470857 Completed - Inflammation Clinical Trials

Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.

Start date: June 19, 2017
Phase:
Study type: Observational

The research aims to determine the parameters of oxidative stress and inflammatory processes and compare these parameters with the image obtained using positron emission tomography (PET) with 2-deoxy-2-[fluorine-18]fluoro- D-glucose (18F-FDG) integrated with computed tomography (CT) in the group of oncological patients.

NCT ID: NCT03470376 Completed - Inflammation Clinical Trials

NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients

NU-TRY(HIV)
Start date: January 15, 2017
Phase: Phase 4
Study type: Interventional

The effects of a nutraceutical combination (NC) containing low-dose monacolin K and berberine on lipid profile, proprotein convertase subtilisin/kexin type 9 (PCSK9), subclinical inflammation and arterial stiffness were investigated in human immunodeficiency virus (HIV)-infected patients receiving stable antiretroviral therapy (ART).

NCT ID: NCT03469869 Completed - Obesity Clinical Trials

Effects of Balanced and Sustainable Diet Application for Insulin Resistance and Inflammation Marker of Obese People

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of balanced and sustainable diet application on fat composition, insulin resistance and inflammation marker in obese people. Intervention: Obese subject will receive intervention on balanced and sustainable diet application Control: Obese subject will receive a balanced diet application only

NCT ID: NCT03467997 Recruiting - Inflammation Clinical Trials

Mental Stress & Diesel Exhaust on Cardiovascular Health

DESTRESS
Start date: March 22, 2018
Phase: N/A
Study type: Interventional

This study uses an experimental design to conduct a double-blind, randomized, crossover study where participants receive both diesel exhaust and a mental stress test in a controlled setting. My hypothesis is that the synergistic effect of stress and air pollution will result in higher levels of stress and inflammation (measured via biological markers) as well as poorer cardiovascular disease related outcomes compared to the independent effect of each exposure separately.

NCT ID: NCT03466879 Completed - Sinus; Inflammation Clinical Trials

A User Study of SYNUS Pain Relief Made by Tivic Health Systems

Start date: February 2, 2018
Phase:
Study type: Observational

Demonstrate the ability of subjects suffering from sinus pain to self-treat with the SYNUS Pain Relief device and to obtain pain relief compared to a sham/placebo device.

NCT ID: NCT03463239 Not yet recruiting - Urologic Diseases Clinical Trials

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Start date: January 2025
Phase: Phase 1
Study type: Interventional

The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of complex penile deformities. Autologous endothelial and smooth muscle cells obtained from enrolled subjects' corpora cavernosa biopsy sample, will be culture expanded in vitro and used to seed decellularized corpora cavernosa + albuginea obtained from cadaveric-donors to create autologous bioengineered corpora cavernosa/albuginea constructs for repair of damaged penile tissues.